載入...
Activation of protein phosphatase 2A tumor suppressor as potential treatment of pancreatic cancer
We utilized three tiers of screening to identify novel therapeutic agents for pancreatic cancers. First, we analyzed 14 pancreatic cancer cell lines against a panel of 66 small‐molecule kinase inhibitors and dasatinib was the most potent. Second, we performed RNA expression analysis on 3 dasatinib‐r...
Na minha lista:
發表在: | Mol Oncol |
---|---|
Main Authors: | , , , , , , , , , , , , , |
格式: | Artigo |
語言: | Inglês |
出版: |
John Wiley and Sons Inc.
2015
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4387089/ https://ncbi.nlm.nih.gov/pubmed/25637283 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2015.01.002 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|